Waldemar Priebe

Waldemar Priebe

Auto-generated profile, based on publicly available information

Waldemar Priebe

The University of Texas M. D. Anderson Cancer Center

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
XQXiaogang Qu
Xiaogang Qu
JTJohn O. Trent
John O. Trent
IFIzabela Fokt
Izabela Fokt
WPWaldemar Priebe
Waldemar Priebe
JCJonathan B. Chaires
Jonathan B. Chaires
The binding interactions of (−)-daunorubicin (WP900), a newly synthesized enantiomer of the anticancer drug (+)-daunorubicin, with right- and left-handed DNA, have been studied quantitatively by equilibrium dialysis, fluorescence spectroscopy, and circular dichroism. (+)-Daunorubicin binds selectively to right-handed DNA, whereas the enantiomeric WP900 ligand binds selectively to left-handed DNA. Further, binding of the enantiomeric pair to DNA is clearly chirally selective, and each of the enantiomers was found to act as an allosteric effector of DNA conformation. Under solution conditions that initially favored the left-handed conformation of [poly(dGdC)]2, (+)-daunorubicin allosterically converted the polynucleotide to a right-handed intercalated form. In contrast, under solution conditions that initially favored the right-handed conformation of [poly(dGdC)]2, WP900 converted the polynucleotide to a left-handed form. Molecular dynamics studies by using theamberforce field resulted in a stereochemically feasible model for the intercalation of WP900 into left-handed DNA. The chiral selectivity observed for the DNA binding of the daunorubicin/WP900 enantiomeric pair is far greater than the selectivity previously reported for a variety of chiral metal complexes. These results open a new avenue for the rational design of potential anticancer agents that target left-handed DNA.

23 March 2006 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
TLTheodore J. Lampidis
Theodore J. Lampidis
MKMetin Kurtoglu
Metin Kurtoglu
JMJohnathan C. Maher
Johnathan C. Maher
HLHuaping Liu
Huaping Liu
AKAwtar Krishan
Awtar Krishan
WPWaldemar Priebe
Waldemar Priebe

1 January 2001
Verified
Book Chapter
Closed access
PDF file
WPWaldemar Priebe
Waldemar Priebe
GGGrzegorz Grynkiewicz
Grzegorz Grynkiewicz

20 May 2015 in Crystal Growth & Design
Verified
Journal Article
Closed access
MMMaura Malinska
Maura Malinska
IFIzabela Fokt
Izabela Fokt
WPWaldemar Priebe
Waldemar Priebe
KWKrzysztof Woźniak
Krzysztof Woźniak